IYE iShares U.S. Energy ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| XOM | 22.98% |
| CVX | 16.06% |
| COP | 6.61% |
| WMB | 4.03% |
| EOG | 3.61% |
| SLB | 3.54% |
| VLO | 3.40% |
| PSX | 3.33% |
| MPC | 3.32% |
| KMI | 2.89% |
ETF Analysis
Fund Overview
iShares U.S. Energy ETF (IYE) currently reports 38 stock positions (subject to change), placing it in the diversified without being diffuse range by holdings breadth. The top line-up is XOM (22.98%), CVX (16.06%), COP (6.61%), with XOM as the largest single weight at 22.98%. Together, the top three holdings account for 45.65%, which represents a dominant share and increases sensitivity to the performance of a narrow leadership group. Taken together, the portfolio's structure reflects a deliberate trade-off between conviction at the top and risk spreading across the broader holding set.
Profitability & Capital Efficiency
On a capital return basis, ROIC is 9.68%, WACC is 6.40%, and the economic spread is 3.28%. On balance, the economic spread is positive but compressed — adequate for value preservation, less convincing for aggressive compounding. Supporting metrics show ROE at 14.53% and ROA at 5.68%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.
Valuation
From a pricing standpoint, the portfolio sits at trailing P/E of 22.15, forward P/E of 17.03, PEG of 2.18. The gap between trailing and forward multiples is meaningful but not wide — the market appears to be pricing a constructive but controlled earnings trajectory. The growth-adjusted multiple is neither a strong buy signal nor a clear warning — it sits in the range where execution quality will determine whether the price is ultimately justified. A current ratio of 1.20 signals that short-term coverage is tighter than typical across the holding set. In total, the multiple and liquidity readings describe a portfolio where valuation is a secondary risk relative to earnings delivery — the numbers are defensible if estimates hold.
Margins & Cash Generation
Stripping to unit economics, gross margin sits at 40.34%, operating margin at 17.84%, and free cash flow margin at 10.85%. Gross margins are healthy, suggesting solid pricing power across the underlying holdings. The operating margin reading is constructive, suggesting management teams are managing overhead costs effectively. At this FCF margin level, cash conversion is functional without being a standout feature of the portfolio's quality profile. Across the three margin layers, the picture is inconsistent — a reminder that aggregate metrics can mask meaningful variation at the individual holding level.
Growth & Forward Outlook
Revenue trends and analyst expectations together suggest: TTM revenue growth of 4.44% indicating muted but still positive top-line momentum across the portfolio, while the estimated 12-month price change of -2.93%, where consensus targets point to downside risk over the next 12 months. At 30.0%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. There is always distance between what is reported and what is priced; the question of whether that distance is closing or widening is what makes the setup interesting. In either direction, the fundamental driver of returns will be whether the underlying businesses can sustain the trajectory that is already being priced. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
HoldThe balance of evidence suggests a neutral posture is appropriate — there are merits here, but also reasons for caution that limit conviction at current levels.
These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.